GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » YoY Rev. per Sh. Growth

ME Therapeutics Holding (XCNQ:METX) YoY Rev. per Sh. Growth : 0.00% (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. ME Therapeutics Holding's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2024 was 0.00%.

ME Therapeutics Holding's Revenue per Share for the three months ended in Feb. 2024 was C$0.00.

ME Therapeutics Holding YoY Rev. per Sh. Growth Historical Data

The historical data trend for ME Therapeutics Holding's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding YoY Rev. per Sh. Growth Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
YoY Rev. per Sh. Growth
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial - - - - -

ME Therapeutics Holding YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

ME Therapeutics Holding's YoY Rev. per Sh. Growth for the fiscal year that ended in Aug. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Aug. 2023 )
=(Revenue per Share (A: Aug. 2023 )-Revenue per Share (A: Aug. 2022 ))/ | Revenue per Share (A: Aug. 2022 ) |
=(0-0)/ | 0 |
=N/A %

ME Therapeutics Holding's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Feb. 2024 )
=(Revenue per Share (Q: Feb. 2024 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines